Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vsee Health (VSEE) Notes Payables (2022 - 2025)

Vsee Health filings provide 4 years of Notes Payables readings, the most recent being $1.0 million for Q3 2025.

  • On a quarterly basis, Notes Payables fell 65.56% to $1.0 million in Q3 2025 year-over-year; TTM through Sep 2025 was $1.0 million, a 65.56% decrease, with the full-year FY2024 number at $3.2 million, up 1289.38% from a year prior.
  • Notes Payables hit $1.0 million in Q3 2025 for Vsee Health, down from $2.9 million in the prior quarter.
  • In the past five years, Notes Payables ranged from a high of $3.2 million in Q4 2024 to a low of $131431.0 in Q2 2023.
  • Median Notes Payables over the past 4 years was $1.0 million (2025), compared with a mean of $1.5 million.
  • Biggest five-year swings in Notes Payables: soared 1532.94% in 2024 and later plummeted 65.56% in 2025.
  • Vsee Health's Notes Payables stood at $292800.0 in 2022, then dropped by 20.16% to $233774.0 in 2023, then soared by 1289.38% to $3.2 million in 2024, then plummeted by 68.34% to $1.0 million in 2025.
  • The last three reported values for Notes Payables were $1.0 million (Q3 2025), $2.9 million (Q2 2025), and $2.6 million (Q1 2025) per Business Quant data.